Accelerate Diagnostics, Inc. (NASDAQ:AXDX)
Industry: Healthcare

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. It offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms, as well as yeast. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was founded in 1982 and is headquartered in Tucson, Arizona.

Current Quote*
Last: $8.091
Change: -0.239
Book: $Unk
Volume: 104,094

As Of: 05/29 13:01 ET
*Quotes delayed by 20min.

BuyIns.Net Alerts for Symbol AXDX

Graphs for AXDX

3 Month Graph

6 Month Graph

1 Year Graph